Pulmonary hypertension
Conditions
Interventions
Severe cardiac adverse event group:none
No serious adverse cardiac events:none
Sponsors
West China Second Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant patients with pulmonary hypertension who were treated at West China Second Hospital of Sichuan University from 2009 to February 2023: 1. Patients who received UCG monitoring in our hospital; 2. Patients who conform to echocardiographic criteria of pulmonary hypertension(PAP >35 mmHg); 3. Patients with complete medical record.
Exclusion criteria
Exclusion criteria: Pregnant women with pulmonary hypertension with incomplete clinical data were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severe arrhythmia;New York Heart Association (NYHA) Class III or IV;Cardiac arrest;Deaths from cardiovascular causes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Year;Body mass index;Parity;Nationality;Medical compliance;Education level;Cyanosis;Albumin;Hemoglobin;Hypertension;Endocrine disease;Autoimmune disease;Respiratory disease;Liver disease;Kidney disease;Ejection fraction;Diagnosis of pulmonary hypertension during pregnancy;Heart disease;Cardiac therapy before pregnancy;Eisenmenger syndrome;Pericardial effusion;Moderate to severe mitral regurgitation;Moderate to severe tricuspid regurgitation;Right heart enlargement;Pulmonary artery pressure classification;Gestational age at delivery;Mode of termination of pregnancy;Mode of anesthesia ;ICU treatment; Length of ICU stay;Length of hospital stay;Fetal death;Neonatal death;Preterm birth;Low birth weight;Neonatal intensive care unit (NICU) treatment; | — |
Countries
China
Contacts
Public ContactXiaoqin Jiang
West China Second Hospital, Sichuan University
Outcome results
None listed